Research progress of electric field in the treatment of glioma

doi:10.3760/cma.j.issn.1673-422X.2017.06.016

Abstract

Abstract: Electric field treatment of tumor technology is of great significance in the treatment of glioma, including direct current electric field and alternating electric field. Direct current electric field affects the migration of glioma cells, and can be used as a new clue for the treatment of glioma. While alternating electric field can inhibit the proliferation and invasion of glioma cells, and induce apoptosis, and can obviously prolong the survival period of patients with glioma and improve their quality of life.

Key words: Glioma, Electromagnetic fields, Intermediate frequency alternating electric field

Mao Yun, Li Liya. Research progress of electric field in the treatment of glioma[J]. Journal of International Oncology, 2017, 44(6): 464-.

References

［1］ Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review［J］. JAMA, 2013, 310(17): 1842-1850. DOI: 10.1001/jama.2013.280319. ［2］ Liu Y, Yan W, Zhang W, et al. MiR218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1［J］. Oncol Rep, 2012, 28(3): 1013-1021. DOI: 10.3892/or.2012.1902. ［3］ Griffin M, Iqbal SA, Sebastian A, et al. Degenerate wave and capacitive coupling increase human MSC invasion and proliferation while reducing cytotoxicity in an in vitro wound healing model［J］. PLoS One, 2011, 6 (8): e23404. DOI: 10.1371/journal.pone.0023404. ［4］ Creecy CM, O′neill CF, Arulanandam BP, et al. Mesenchymal stem cell osteodifferentiation in response to alternating electric current［J］. Tissue Eng Part A, 2013, 19(34): 467-474. DOI: 10.1089/ten.tea.2012.0091. ［5］ Zhao Z, Watt C, Karystinou A, et al. Directed migration of human bone marrow mesenchymal stem cells in a physiological direct current electric field［J］. Eur Cell Mater, 2011, 22: 344-358. ［6］ Yamashita M. Fluctuations in nuclear envelope′s potential mediate synchronization of early neural activity［J］. Biochem Biophys Res Commun, 2011, 406(1): 107-111. DOI: 10.1016/j.bbrc.2011.02.004. ［7］ Cuzick J, Holland R, Barth V, et al. Electropotential measurements as a new diagnostic modality for breast cancer［J］. Lancet, 1998, 352 (9125): 359-363. ［8］ Mycielska ME, Djamgoz MB. Cellular mechanisms of directcurrent electric field effects: galvanotaxis and metastatic disease［J］. J Cell Sci, 2004, 117 (Pt 9): 1631-1639. ［9］ Cao L, Wei D, Reid B, et al. Endogenous electric currents might guide rostral migration of neuroblasts［J］. EMBO Rep, 2013, 14(2): 184-190. DOI: 10.1038/embor.2012.215. ［10］ Cuddapah VA, Robel S, Watkins S, et al. A neurocentric perspective on glioma invasion［J］. Nat Rev Neurosci, 2014, 15(7): 455-465. DOI: 10.1038/nrn3765. ［11］李飞. 脑胶质瘤侵袭生长的相关因素及直流电场诱导U87胶质瘤细胞定向迁移［D］. 重庆: 第三军医大学, 2011. ［12］ Li F, Chen T, Hu S, et al. Superoxide mediates direct current electric fieldinduced directional migration of glioma cells through the activation of AKT and ERK［J］. PLoS One, 2013, 8(4): e61195. DOI: 10.1371/journal.pone.0061195. ［13］ Huang YJ, Hoffmann G, Wheeler B, et al. Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells［J］. Sci Rep, 2016, 6: 21583. DOI: 10.1038/srep21583. ［14］ Wu S, Wang Y, Guo J, et al. Nanosecond pulsed electric fields as a novel drug free therapy for breast cancer: an in vivo study［J］. Cancer Lett, 2014, 343(2): 268-274. DOI: 10.1016/j.canlet.2013.09.032. ［15］ Guo F, Yao C, Li C, et al. In vivo evidences of nanosecond pulsed electric fields for melanoma malignancy treatment on tumorbearing BALB/c nude mice［J］. Technol Cancer Res Treat, 2014, 13(4): 337-344. DOI: 10.7785/tcrt.2012.500385. ［16］ Kirson ED, Gurvich Z, Schneiderman R, et al. Disruption of cancer cell replication by alternating electric fields［J］. Cancer Res, 2004, 64(9): 3288-3295. DOI: 10.1158/00085472. ［17］ Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality［J］. Am Soc Clin Oncol Educ Book, 2012, 32: 126-131. DOI: 10.14694/EdBook_AM.2012.32.126. ［18］ Gera N, Yang A, Holtzman TS, et al. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit［J］. PLoS One, 2015, 10(5): e0125269. DOI: 10.1371/journal.pone.0125269. ［19］ Kim EH, Song HS, Yoo SH, et al. Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis［J］. Oncotarget, 2016, 7(40): 65125-65136. DOI: 10.18632/oncotarget.11372. ［20］ Kirson ED, Dbal V, Tovarys F, et al. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors［J］. Proc Nat Acad Sci USA, 2007, 104(24): 10152-10157. DOI: 10.1073/pnas.0702916104. ［21］ Wenger C, Salvador R, Basser PJ, et al. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study［J］. Phys Med Biol, 2015, 60(18): 7339-7357. DOI: 10.1088/00319155/60/18/7339. ［22］ Stupp R, Wong ET, Kanner AA, et al. NovoTTF100A versus physician′s choice chemotherapy in recurrent glioblastoma: a randomised phase Ⅲ trial of a novel treatment modality［J］. Eur J Cancer, 2012, 48(14): 2192-2202. DOI: 10.1016/j.ejca.2012.04.011. ［23］ Stupp R, Taillibert S , Kanner AA, et al. Maintenance therapy with tumortreating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial［J］. JAMA, 2015, 314 (23): 2535-2543. DOI: 10.1001/jama.2015.16669. ［24］ Ansstas G, Tran DD. Treatment with tumortreating fields therapy and pulse dose bevacizumab in patients with bevacizumabrefractory recurrent glioblastoma: a case series［J］. Case Rep Neurol, 2016, 8(1): 1-9. DOI: 10.1159/000442196. ［25］ Wong ET, Lok E, Swanson KD. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation［J］. Cancer Med, 2015, 4(3): 383-391. DOI: 10.1002/cam4.421. ［26］ Fonkem E, Wong ET. NovoTTF100A: a new treatment modality for recurrent glioblastoma［J］. Expert Rev Neurother, 2012, 12(8): 895-899. ［27］ Turner SG, Gergel T, Wu H, et al. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM100A system［J］. World J Surg Oncol, 2014, 12: 162. DOI: 10.1186/1477781912162.

[1]	Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei. Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction [J]. Journal of International Oncology, 2024, 51(4): 193-197.
[2]	Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361.
[3]	Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83.
[4]	Kong Chunyu, Sun Pengfei. SLC7A11 and glioma [J]. Journal of International Oncology, 2022, 49(10): 604-607.
[5]	Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma [J]. Journal of International Oncology, 2021, 48(6): 362-365.
[6]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.
[7]	Sun Yanqi, Ren Yeqing, Guo Geng. Mechanism of inhibitory effect of interferon and its related signal pathway on the invasion of glioma [J]. Journal of International Oncology, 2021, 48(3): 172-175.
[8]	Zhao Congxuan, Yu Tao. Mining and prediction of glioma-related genes [J]. Journal of International Oncology, 2020, 47(5): 293-296.
[9]	Nan Yang, Zhong Yue. New research advances of long non-coding RNA in glioma [J]. Journal of International Oncology, 2020, 47(2): 98-102.
[10]	Zhang Wen, Song Qibin, Hu Weiguo. Clinical application of multimodal magnetic resonance imaging in glioma [J]. Journal of International Oncology, 2020, 47(11): 686-690.
[11]	Chen Liang, Qin Jun, Lei Junrong, Liu Jun, Wang Lu. miR-1254 inhibits the proliferation and invasion of glioma cells by targeting CSF-1 [J]. Journal of International Oncology, 2020, 47(10): 577-584.
[12]	Zhang Qianhui, Zhang Yang, Su Weipeng, Zhang Song′an, Liu Pan, Zhao Huarong. Expressions of LSD1, MGMT and Ki-67 in high-grade glioma and their influences on prognosis [J]. Journal of International Oncology, 2019, 46(9): 519-525.
[13]	Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491.
[14]	Yu Xuejuan, An Hongwei, Sun Yamei, Jiang Zheng, Zhang Xuehai, Yang Wenjing, Zhang Wei. Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance [J]. Journal of International Oncology, 2019, 46(12): 718-722.
[15]	Lu Di, Zhang Jundong, Guo Geng, Wang Xiaogang. Research progress of interferon induced glioma cell apoptosis [J]. Journal of International Oncology, 2018, 45(7): 432-435.